CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 395 enrolled
Drug / intervention
Data collectionother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01772160
NCT01772160N/ACompleted

Population Based Surveillance to Estimate the Burden of Herpes Zoster and Post-herpetic Neuralgia in Italy

GlaxoSmithKline·observational·Posted Jan 21, 2013·Updated May 22, 2020

In Brief

An observational study evaluating Data collection for Herpes Zoster and Herpes Zoster Vaccine. Completed, enrolled 395 participants across 43 sites.

Detailed Summary

The purpose of this study is to collect data on the incidence, complications, economic burden and impact on the quality of life in adults aged ≥ 50 years with HZ disease in Italy.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesItaly
Collaborators--

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedJan 21, 2013
Enrollment StartFeb 26, 2013
Primary CompletionOct 5, 2016
TodayJul 2, 2026
Enrollment to primary: 3.6 yearsPosted 13.4 years ago

Interventions

Data collectionother

HZ/PHN booklet, HZ/PHN file and logbook. HZ/PHN booklet will be completed by the patient and the HZ/PHN file and logbook will be completed by the participating general practitioner.